Abstract

Background and PurposeSubarachnoid hemorrhage (SAH) is a life-threatening subtype of stroke with high rates of mortality. In the early stages of SAH, neuroinflammation is one of the important mechanisms leading to brain injury after SAH. In various central nervous system diseases, activation of RARα receptor has been proven to demonstrate neuroprotective effects. This study aimed to investigate the anti-inflammatory effects of RARα receptor activation after SAH.MethodsInternal carotid artery puncture method used to established SAH model in Sprague-Dawley rats. The RARα specific agonist Am80 was injected intraperitoneally 1 hour after SAH. AGN196996 (specific RARα inhibitor), Msr1 siRNA and LY294002 (PI3K-Akt inhibitor) were administered via the lateral ventricle before SAH. Evaluation SAH grade, neurological function score, blood-brain barrier permeability. BV2 cells and SH-SY5Y cells were co-cultured and stimulated by oxyhemoglobin to establish an in vitro model of SAH. RT-PCR, Western blotting, and immunofluorescence staining were used to investigate pathway-related proteins, microglia activation and inflammatory response. Results: The expression of RARα, Mafb, and Msr1 increased in rat brain tissue after SAH. Activation of the RARα receptor with Am80 improved neurological deficits and attenuated brain edema, blood brain barrier permeability. Am80 increased the expression of Mafb and Msr1, and reduced neuroinflammation by enhancing the phosphorylation of Akt and by inhibiting the phosphorylation of NF-κB. AGN196996, Msr1 siRNA, and LY294002 reversed the therapeutic effects of Am80 by reducing the expression of Msr1 and the phosphorylation of Akt. In vitro model of SAH, Am80 promoted M1-to-M2 phenotypic polarization in microglia and suppressed the nuclear transcription of NF-κB.ConclusionActivation of the RARα receptor attenuated neuroinflammation by promoting M1-to-M2 phenotypic polarization in microglia and regulating the Mafb/Msr1/PI3K-Akt/NF-κB pathway. RARα might serve as a potential target for SAH therapy.

Highlights

  • Subarachnoid hemorrhage (SAH) is a fatal form of cerebrovascular disease that accounts for 5% - 10% of all stroke types and represents a serious public health problem [1]

  • There was no significant difference in the SAH grade score of all the SAH groups (Figure 1C)

  • Double immunofluorescence staining further confirmed that RARa, musculoaponeurotic fibrosarcoma oncogene homolog B (Mafb), and Macrophage scavenger receptor 1 (Msr1), co-localized with microglia in the cerebral cortex (Figure 2E)

Read more

Summary

Introduction

Subarachnoid hemorrhage (SAH) is a fatal form of cerebrovascular disease that accounts for 5% - 10% of all stroke types and represents a serious public health problem [1]. Brain injury (EBI) is an important factor underlying the high rates of mortality and disability in patients after SAH. Within 72 hours of SAH, activated microglia release many inflammatory factors, amplify the inflammatory response, and aggravate nerve function damage. M1 microglia aggravates brain damage by releasing pro-inflammatory cytokines, including IL-1b, TNF-a, and IL-6. M2 microglia provide neuroprotective effects by releasing antiinflammatory factors [6, 7]. Subarachnoid hemorrhage (SAH) is a life-threatening subtype of stroke with high rates of mortality. In the early stages of SAH, neuroinflammation is one of the important mechanisms leading to brain injury after SAH. In various central nervous system diseases, activation of RARa receptor has been proven to demonstrate neuroprotective effects. This study aimed to investigate the anti-inflammatory effects of RARa receptor activation after SAH

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call